IMPACT OF PrEP AND TasP ON INCIDENCE OF HIV DIAGNOSES IN 48 HIGHEST-BURDEN US AREAS
Use of Tenofovir Disoproxil/Emtricitabine (TVD) for Pre-Exposure Prophylaxis (PrEP) has significantly reduced the HIV diagnosis rate in many US states, independent of the effect of treatment as prevention (TasP). Using publicly available HIV surveillance data on HIV diagnoses from 105 US metropolitan statistical areas (MSAs) (2012-2017), virologic suppression data from 38 US states and DC…